In Stock, Ready to Ship!
$65.00 — or subscribe and save 20%
PT-141 (Bremelanotide) is a lab-grade melanocortin-4 receptor agonist peptide designed for advanced neuromodulation and vascular signaling research. Widely cited in male sexual behavior and penile blood-flow studies, PT-141 offers precise MC4R activation without off-target erythropoietic effects. Each vial is manufactured under ISO-certified conditions, verified to ≥99% purity, and supplied with a full Certificate of Analysis (COA).
Peptides are not ready to use. Must purchase BAC water for reconstitution.
KEY HIGHLIGHTS
Journal of Neuroscience Research. Demonstrated PT-141’s MC4R-mediated increases in male mounting behavior.
SEE STUDY HERE
European Journal of Pharmacology. Documented dose-dependent penile blood flow changes in rabbit models.
SEE STUDY HERE
Journal of Sexual Medicine. Evaluated PT-141’s effects on erectile function and arousal indices in non-human primates.
SEE STUDY HERE
PT-141 is studied for its MC4R-mediated sexual arousal and vascular signaling effects in preclinical models.
Pharmacokinetic studies show a half-life of approximately 2–3 hours in rodent models, with functional effects observed up to 6 hours post-dose.
Yes. Studies have also evaluated PT-141’s effects on female sexual incentive and hormonal responses in rodent assays.
No. PT-141 is strictly for research use only and is not approved for therapeutic applications.
Reconstitute with SWFI or BAC following your lab’s SOPs to achieve the desired concentration.
Store lyophilized peptide at –20 °C; maintain reconstituted solutions at 2–8 °C for up to 7 days.
PT-141 is synthesized in ISO-certified U.S. laboratories, with batch testing for purity, potency, and safety compliance.
Don't hestitate to contact us
End of Content.